62nd Scientific Sessions of the American Diabetes Association, San Francisco Forecasting Coronary Case Fatality in Type 2 Diabetes: A UKPDS Risk Engine Equation
Stevens RJ, Coleman RL, Adler AI, Stratton IM, Holman RR
Diabetes 2002;51:Suppl 2:A172
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: glucose control and weight gain in a 1 year community-based study
Potts NJ, Dudley CA, Holman RR
Diabetologia 2002;45:Suppl 2:A243 [Abstract]
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
Mohanlal N, Holman RR
Diabetologia 2002;45:Suppl 2:A246 [Abstract]
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: early use of combination therapies and insulin in general practice.
Potts NJ, Dudley CA, Holman RR
Diabetologia 2002;45:Suppl 2:A265 [Abstract]
21st Joint Meeting of the British Endocrine Societies, Harrogate Diabetes and vascular risk
Rury R Holman
Endocrine Abstracts 2002;3:S14
193rd Meeting of the Society for Endocrinology and Society for Endocrinology joint Endocrinology and Diabetes Day, London The Role of Metformin
RR Holman, IM Stratton
Endocrine Abstracts 2002;4:DS8
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk
